MYC and colonic neoplasm: For example, by virtue of actions that accelerate mRNA degradation and inhibit transcript splicing, butyrate reduces expression of c-Myc, a key proto-oncogene [11–13]; butyrate treatment of human colon cancer cell lines reduces c-Myc mRNA and protein levels [14].